# AI² Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ai-robotics-3

- Industry: Industrial Machinery
- Headquarters: Shenzhen, China
- Website: www.ai2robotics.com
- Total disclosed funding: $145M
- Latest round: Series B (Feb 23, 2026)
- Investors on record: 14

## About

Based in Shenzhen, China and founded in 2023, Zhipingfang (Shenzhen) Technology Co., Ltd, trading under the name AI² Robotics, provides general purpose robotic solutions for the industrials industry. The company was established by Dr. Yandong "Eric" Guo to develop AGI-native robots using the Alpha Brain embodied foundation model. 

In June 2026, AI² Robotics raised CNY 5 billion in venture fundings.


The company manufactures the "AlphaBot Series," a general-purpose robot designed for tasks such as material handling, assembly and device operation in cleanroom and industrial settings. Additionally, the firm offers the "Alpha Brain" embodied foundation model, which utilizes visual language action (VLA) technology to enable spatial understanding and complex task reasoning.

The company’s revenue is generated by the sale of general-purpose robots and integrated software solutions to industrial clients. 

Moving forward, AI² Robotics aims to accelerate global adoption of general-purpose robots, take over repetitive and hazardous tasks, enhance human capabilities, and build a more efficient, reliable, and sustainable future.

## Funding rounds

- Series B, Feb 23, 2026, $145M — Guotai Haitong, Baidu Capital, Cedarlake Capital, CRRC Guochuang Capital Management, Yusys Technologies Co., Ltd., Qingdao Sentury Tire Co., Ltd.
- Series A, Jan 22, 2026 — Changzhou Gaoxintou Venture, CRRC Guochuang Capital Management, Shanghai Chengpu Investment, Tianfu Science and Technology Venture Capital, Wuxi Kesheng Private Equity Fund
- Series A, Sep 1, 2025 — Shenzhen Capital Real Estate Fund, Dunhong Capital Management, Bloomage Biotechnology Corporation, Beijing Guotou Chuangying Investment Management

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series A
- Dunhong Capital Management (https://capitalatlas.ai/funds/dunhong-capital-management) — Series A
- Bloomage Biotechnology Corporation — Series A
- Beijing Guotou Chuangying Investment Management — Series A
- Changzhou Gaoxintou Venture (https://capitalatlas.ai/funds/changzhou-gaoxintou-venture) — Series A
- CRRC Guochuang Capital Management (https://capitalatlas.ai/funds/crrc-guochuang-capital-management) — Series A, Series B
- Shanghai Chengpu Investment (https://capitalatlas.ai/funds/shanghai-chengpu-investment) — Series A
- Tianfu Science and Technology Venture Capital (https://capitalatlas.ai/funds/tianfu-science-and-technology-venture-capital) — Series A
- Wuxi Kesheng Private Equity Fund (https://capitalatlas.ai/funds/wuxi-kesheng-private-equity-fund) — Series A
- Guotai Haitong — Series B
- Baidu Capital (https://capitalatlas.ai/funds/baidu-capital) — Series B
- Cedarlake Capital (https://capitalatlas.ai/funds/cedarlake-capital) — Series B
- Yusys Technologies Co., Ltd. — Series B
- Qingdao Sentury Tire Co., Ltd. — Series B